You are here
Valeant files annual report, says in compliance with covenants
[BENGALURU] Beleaguered Canadian drugmaker Valeant Pharmaceuticals International Inc filed its annual report on Friday, which will help it stave of a default on its US$30 billion debt.
The company said it was in compliance with its credit agreement and senior note indentures.
Valeant said no additional restatements were required beyond those previously disclosed.